1-(4-Phenoxybenzyl) 5-Aminouracil Derivatives and Their Analogues - Novel Inhibitors of Human Adenovirus Replication
- PMID: 30116616
- PMCID: PMC6087815
1-(4-Phenoxybenzyl) 5-Aminouracil Derivatives and Their Analogues - Novel Inhibitors of Human Adenovirus Replication
Abstract
Adenovirus infections are characterized by widespread distribution. The lack of causal therapy, which is effective in treating this group of diseases, explains the need for new therapeutic drugs. Notably, anti-adenoviral activity of [4-(phenoxy)benzyl]-5-(phenylamino)-6-azauracil, 1-[4-(phenoxy)benzyl]-5-(morpholino) uracil, 1-[4-(4-chlorophenoxy)benzyl]-5-(morpholino) uracil, and 1-[4-(4-fluorophenoxy)-benzyl]-5-(morpholino) uracil was observed.
Keywords: 5-aminouracil derivatives; Human adenovirus; adenovirus replication; inhibitors of adenovirus replication.
Figures
References
-
- Gupta P., Tobias J.D., Goyal S., Hervie P., Harris J.B., Sadot E., Noviski N.. J. Intensive Care Med. 2011;26(4):267–272. - PubMed
-
- Gonzalez-Lopez J.J., Morcillo-Laiz R., Munoz-Negrete F.J.. Arch. Soc. Esp. Oftalmol. 2013;88(3):108–115. - PubMed
-
- Eckardt A.J., Baumgart D.C.. Recent Pat Antiinfect Drug Discov. 2011;6(1):54–63. - PubMed
LinkOut - more resources
Full Text Sources